Naprosyn and Ezetimibe drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Naprosyn (naproxen) and Ezetimibe (ezetimibe). Common drug interactions include activities of daily living impaired among females and radiation pneumonitis among males.
The phase IV clinical study analyzes what interactions people have when they take Naprosyn and Ezetimibe. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Naprosyn?
Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.
What is Ezetimibe?
Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.
13 people who take Naprosyn and Ezetimibe together, and have interactions are studied.

What are the common drug interactions of Naprosyn and Ezetimibe, by gender? *:
female:
- Activities of daily living impaired
- Blood pressure systolic increased
- Blood sodium decreased
- Burning sensation
- Colon cancer
- Colorectal cancer metastatic (cancer of colon and rectal spreads to other parts)
- Death
- Diarrhoea
- Drug hypersensitivity
- Dysphonia (speech disorder attributable to a disorder of phonation)
male:
- Radiation pneumonitis (inflammation of lung due to radiation)
- Arthralgia (joint pain)
- Anxiety
- Aphasia (damage to the parts of the brain that control language)
- Ataxia (loss of full control of bodily movements)
- Atelectasis (partial or complete collapse of the lung)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Blood pressure increased
- Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
- Colonic polyp (extra part of colon tissue grow in intestine)
What are the common drug interactions of Naprosyn and Ezetimibe, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Abasia (inability to walk)
- Alcohol abuse
- Alcohol poisoning
- Anxiety
- Aphasia (damage to the parts of the brain that control language)
- Arthralgia (joint pain)
- Ataxia (loss of full control of bodily movements)
- Atelectasis (partial or complete collapse of the lung)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
40-49:
n/a
50-59:
- Adenocarcinoma pancreas (cancer of pancreas)
- Hepatic cancer stage iv
- Pancreatic carcinoma stage iv (pancreatic cancer stage iv)
60+:
- Radiation pneumonitis (inflammation of lung due to radiation)
- Activities of daily living impaired
- Diarrhoea
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Feeling cold
- Gait disturbance
- Gastric ulcer haemorrhage (bleeding ulcer of stomach)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haematocrit decreased
- Haemoglobin decreased
What are the existing conditions these people have? *
- High Blood Pressure: 3 people, 23.08%
- Joint Pain: 2 people, 15.38%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 15.38%
- Dyslipidaemia (abnormal amount of lipids): 2 people, 15.38%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 15.38%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
- Urinary Tract Infection: 1 person, 7.69%
- Erection Problems: 1 person, 7.69%
- Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 7.69%
- Catheter Site Pain: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Naprosyn and Ezetimibe?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Naprosyn and Ezetimibe:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Naprosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ezetimibe:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Naprosyn and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ezetimibe and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on naproxen and ezetimibe (the active ingredients of Naprosyn and Ezetimibe, respectively), and Naprosyn and Ezetimibe (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Erythromycin cause Ejection Fraction Abnormal? - 3 seconds ago
- Could Valacyclovir cause Immunodeficiency Disorders? - 18 seconds ago
- Drug interactions of Plegridy and Zofran - 24 seconds ago
- Drug interactions of Amitriptyline Hydrochloride and Methylprednisolone - 26 seconds ago
- Drug interactions of Piperacillin and Allopurinol - 32 seconds ago
- Could Ocrevus cause Scab? - 37 seconds ago
- Omega-3 Fatty Acid vs. Rosuvastatin Zinc, side effect and effectiveness comparison - 38 seconds ago
- Drug interactions of Lorazepam and Myorisan - 40 seconds ago
- Could Rezulin cause Drug Withdrawal Syndrome? - 41 seconds ago
- Drug interactions of Amitriptyline Hydrochloride and Haloperidol Decanoate - 46 seconds ago